These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 12480299

  • 1. Polymorphic CYP2C19 and N-acetylation: human variability in kinetics and pathway-related uncertainty factors.
    Dorne JL, Walton K, Renwick AG.
    Food Chem Toxicol; 2003 Feb; 41(2):225-45. PubMed ID: 12480299
    [Abstract] [Full Text] [Related]

  • 2. Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate?
    Dorne JL, Walton K, Slob W, Renwick AG.
    Food Chem Toxicol; 2002 Nov; 40(11):1633-56. PubMed ID: 12176090
    [Abstract] [Full Text] [Related]

  • 3. Human variability in CYP3A4 metabolism and CYP3A4-related uncertainty factors for risk assessment.
    Dorne JL, Walton K, Renwick AG.
    Food Chem Toxicol; 2003 Feb; 41(2):201-24. PubMed ID: 12480298
    [Abstract] [Full Text] [Related]

  • 4. Human variability in xenobiotic metabolism and pathway-related uncertainty factors for chemical risk assessment: a review.
    Dorne JL, Walton K, Renwick AG.
    Food Chem Toxicol; 2005 Feb; 43(2):203-16. PubMed ID: 15621332
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phenotype-genotype relationship and clinical effects of citalopram in Chinese patients.
    Yin OQ, Wing YK, Cheung Y, Wang ZJ, Lam SL, Chiu HF, Chow MS.
    J Clin Psychopharmacol; 2006 Aug; 26(4):367-72. PubMed ID: 16855453
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The role of CYP2C19 in amitriptyline N-demethylation in Chinese subjects.
    Jiang ZP, Shu Y, Chen XP, Huang SL, Zhu RH, Wang W, He N, Zhou HH.
    Eur J Clin Pharmacol; 2002 May; 58(2):109-13. PubMed ID: 12012142
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations.
    Uno T, Niioka T, Hayakari M, Yasui-Furukori N, Sugawara K, Tateishi T.
    Eur J Clin Pharmacol; 2007 Feb; 63(2):143-9. PubMed ID: 17203292
    [Abstract] [Full Text] [Related]

  • 14. The CYP2C19 genotype and the use of oral contraceptives influence the pharmacokinetics of carisoprodol in healthy human subjects.
    Bramness JG, Skurtveit S, Gulliksen M, Breilid H, Steen VM, Mørland J.
    Eur J Clin Pharmacol; 2005 Aug; 61(7):499-506. PubMed ID: 16021435
    [Abstract] [Full Text] [Related]

  • 15. Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes.
    Saito M, Yasui-Furukori N, Uno T, Takahata T, Sugawara K, Munakata A, Tateishi T.
    Br J Clin Pharmacol; 2005 Mar; 59(3):302-9. PubMed ID: 15752376
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes.
    Horai Y, Kimura M, Furuie H, Matsuguma K, Irie S, Koga Y, Nagahama T, Murakami M, Matsui T, Yao T, Urae A, Ishizaki T.
    Aliment Pharmacol Ther; 2001 Jun; 15(6):793-803. PubMed ID: 11380317
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of proton pump inhibitors in children.
    Litalien C, Théorêt Y, Faure C.
    Clin Pharmacokinet; 2005 Jun; 44(5):441-66. PubMed ID: 15871633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.